熱門資訊> 正文

PTC Therapeutics报告第二季度业绩

2024-08-09 04:24

PTC治療(PTCT) 0
普拉格能源(PLUG) 0

PTC Therapeutics press release (NASDAQ:PTCT): Q2 Revenue of $187M (-12.5% Y/Y) beats by $5.99M.
Net loss was $99.2 million for the second quarter of 2024, compared to net loss of $198.9 million for the second quarter of 2023.
Cash, cash equivalents, and marketable securities were $1,093.3 million on June 30, 2024, compared to $876.7 million on December 31, 2023.

More on PTC Therapeutics

PTC Therapeutics: Riding The Regulatory Rollercoaster With Translarna
PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts
PTC Therapeutics Q2 2024 Earnings Preview
Biggest stock movers today: PLUG, NKE, DJT, and more
Seeking Alpha’s Quant Rating on PTC Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。